Background: Malignant peripheral nerve sheath tumor (MPNST) is a heterogeneous group of neoplasms that shows divergent differentiation potential, and the cytological findings are largely nonspecific. There are no previous reports specifically alluding to the cytological findings of MPNST showing fibroblastic differentiation (fibroblastic MPNST). Case: A 59-year-old woman with neurofibromatosis type 1 developed a rapidly enlarging tumor on the scalp. A metastatic lesion in the ileum was examined cytologically. Irregularly shaped clusters of spindle cells with wavy or buckled nuclei and fibrillary cytoplasm were found as well as many similar isolated cells. Histopathologically, the tumor showed a spindle cell sarcomatous appearance typical of MPNST. Immunohistochemically, the tumor cells were negative for S-100 protein and epithelial membrane antigen but immunoreactive for vimentin, CD10 and CD34. Ultrastructurally, the tumor cells were not invested by the basal lamina and had abundant rough-surfaced endoplasmic reticulum and a subplasmalemmal accumulation of microfilaments with dense patches. These immunohistochemical and ultrastructural findings were consistent with fibroblastic or myofibroblastic differentiation. Conclusion: Although there are no cytological findings specific for fibroblastic MPNST, the wide spectrum of differentiation in MPNST should be kept in mind during cytological examination of soft tissue sarcomas.

Keywords:
Malignant peripheral nerve sheath tumor, Fibroblastic differentiation, Cytology
1.
Layfield LJ, Anders KH, Glasgow BJ, Mirra JM: Fine-needle aspiration of primary soft-tissue lesions. Arch Pathol Lab Med 1986;110:420–424.
2.
Jiménez-Heffernan JA, López-Ferrer P, Vicandi B, Hardisson D, Gamallo C, Viguer JM: Cytologic features of malignant peripheral nerve sheath tumor. Acta Cytol 1999;43:175–183.
3.
Erlandson RA, Woodruff JM: Peripheral nerve sheath tumors. An electron microscopic study of 43 cases. Cancer 1982;49:273–287.
4.
Herrera GA, de Moraes HP: Neurogenic sarcomas in patients with neurofibromatosis (von Recklinghausen’s disease). Light, electron microscopy and immunohistochemistry study. Virchows Arch A Pathol Anat Histopathol 1984;403:361–376.
5.
Takeuchi A, Ushigome S: Diverse differentiation in malignant peripheral nerve sheath tumours associated with neurofibromatosis-1. An immunohistochemical and ultrastructural study. Histopathology 2001;39:298–309.
6.
Weiss SW, Goldblum JR: Enzinger and Weiss’s Soft Tissue Tumors, ed 5. Philadelphia, Mosby Elsevier, 2008.
7.
Ortiz-Hidalgo C, Weller RO: Peripheral nervous system; in Mills SE (ed): Histology for Pathologists, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2007, pp 241–271.
8.
Hirose T, Scheithauer BW, Sano T: Perineurial malignant peripheral nerve sheath tumor (MPNST). A clinicopathologic, immunohistochemical, and ultrastructural study of seven cases. Am J Surg Pathol 1998;22:1368–1378.
9.
Houreih MA, Eyden B, Deolekar M, Banerjee S: A case of fibroblastic low-grade malignant peripheral nerve sheath tumor – a true neurofibrosarcoma. Ultrastruct Pathol 2007;31:347–356.
10.
Mills AM, Karamchandani JR, Vogel H, Longacre TA: Endocervical fibroblastic malignant peripheral nerve sheath tumor (neurofibrosarcoma). Report of a novel entity possibly related to endocervical CD34 fibrocytes. Am J Surg Pathol 2011;35:404–412.
11.
Hood IC, Qizilbash AH, Young JEM, Archibald SD: Needle aspiration cytology of a benign and a malignant schwannoma. Acta Cytol 1984;28:157–164.
12.
Vendraminelli R, Cavazzana AO, Poletti A, Galligioni A, Pennelli N: Fine-needle aspiration cytology of malignant nerve sheath tumors. Diagn Cytopathol 1992;8:559–562.
13.
McGee RS Jr, Ward WG, Kilpatrick SE: Malignant peripheral nerve sheath tumor. A fine-needle aspiration biopsy study. Diagn Cytopathol 1997;17:298–305.
14.
Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T: Immunohistochemical demonstration of EMA/Glut1-positive perineurial cells and CD34-positive fibroblastic cells in peripheral nerve sheath tumors. Mod Pathol 2003;16:293–298.
15.
Weiss SW, Nickoloff BJ: CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. Am J Surg Pathol 1993;17:1039–1045.
16.
Mechtersheimer G, Möller P: Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors. Am J Pathol 1989;134:961–965.
17.
Rodriguez FJ, Scheithauer BW, Abell-Aleff PC, Elamin E, Erlandson RA: Low grade malignant peripheral nerve sheath tumor with smooth muscle differentiation. Acta Neuropathol 2007;113:705–709.
18.
Joseph NM, Mukouyama Y, Mosher JT, Jaegle M, Crone SA, Dormand EL, Lee KF, Meijer D, Anderson DJ, Morrison SJ: Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells. Development 2004;131:5599–5612.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.